2015: A Blockbuster Year In Health, Life Sciences M&A
Pfizer and Allergan made history on Monday by unveiling a $160 billion proposed stock-for-stock merger, but even without that deal, 2015 would have been a memorable year for mergers and acquisitions...To view the full article, register now.
Already a subscriber? Click here to view full article